ArticleBioengineered2021

Empagliflozin protects diabetic pancreatic tissue from damage by inhibiting the activation of the NLRP3/caspase-1/GSDMD pathway in pancreatic β cells: in vitro and in vivo studies.

Pan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.